Kirkland & Ellis advises Madison Dearborn Partners and its portfolio company Performance Health on the sale of its Biofreeze brand to Reckitt Benckiser Group, which was announced today. Biofreeze is the number one clinically recommended topical pain relief brand in the U.S. The transaction is subject to certain regulatory approvals and customary closing conditions. Read more in Reckitt Benckiser’s press release The Kirkland team included transactional partners Mark Fennell and Dan Hoppe, along with partner Sandy Perl and associates Nicholas Cast, Matthew Hutchinson and Kate Kennedy; tax partners Rachel Cantor and Josh McLane and associate Chris Worek; technology & IP transactions partners Aaron Lorber and Todd Herst and associate Imani Lee; debt finance partners Michael Wright and Kyle Gillen; employee benefits partner Robert Zitko and associate Caitlin Pyrce; labor and employment partner Michael Schulman; executive compensation partner Matthew Shiels and associates Frances Tompson and Tom Kotlowski; environmental partner Toby Chun and associate Zack Tavlin; international trade and national security partner Mario Mancuso and associates Luci Hague and Faith Dibble; real estate partner John Caruso; and healthcare regulatory partner Katie Sullivan and associate Eric Tang; antitrust and competition partners Ian John, Paula Riedel, Marin Boney and Thomas Wilson and associates Jasmine Smith, Philipp Gnatzy and Kelsey Laugel, as well as mergers and acquisitions clearance director Kurt Wunderlich.